148 related articles for article (PubMed ID: 2354386)
1. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
Campbell DR; Flemming BK; Mason WF; Jackson SA; Hirsch DJ; MacDonald KJ
Can Assoc Radiol J; 1990 Jun; 41(3):133-7. PubMed ID: 2354386
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of iohexol, iopamidol and ioxaglate.
Tverdal A; Haider T
Can Assoc Radiol J; 1991 Jun; 42(3):226-7. PubMed ID: 2054686
[No Abstract] [Full Text] [Related]
3. Iohexol, ioxaglate and iopamidol in coronary angiography. A double-blind comparative study of 300 patients.
Soiva M; Hekali P; Keto P; Karumo J; Salonen O; Heikkilä J
Australas Radiol; 1991 May; 35(2):109-11. PubMed ID: 1930006
[TBL] [Abstract][Full Text] [Related]
4. Experience with low osmolar contrast media a clinical and experimental study.
Pokorny L; Nagy E; Vadon G
Ann Radiol (Paris); 1989; 32(1):40-2. PubMed ID: 2742325
[TBL] [Abstract][Full Text] [Related]
5. Three new low-osmolality contrast agents: a comparative study of patient discomfort.
Smith DC; Yahiku PY; Maloney MD; Hart KL
AJNR Am J Neuroradiol; 1988; 9(1):137-9. PubMed ID: 3124566
[TBL] [Abstract][Full Text] [Related]
6. Iohexol and ioxaglate in peripheral angiography.
Stiris MG; Laerum F
Acta Radiol; 1987; 28(6):767-70. PubMed ID: 2962617
[TBL] [Abstract][Full Text] [Related]
7. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography.
Wisneski JA; Gertz EW; Dahlgren M; Muslin A
Am J Cardiol; 1989 Feb; 63(7):489-95. PubMed ID: 2916435
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study.
Liss P; Eklöf H; Hellberg O; Hägg A; Boström-Ardin A; Löfberg AM; Olsson U; Orndahl P; Nilsson H; Hansell P; Eriksson LG; Bergqvist D; Nyman R
J Vasc Interv Radiol; 2005 Jan; 16(1):57-65. PubMed ID: 15640411
[TBL] [Abstract][Full Text] [Related]
9. [Changes in renal function immediately after the angiography].
Murakami R; Tajima H; Kumazaki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jun; 54(7):605-12. PubMed ID: 8065882
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.
Davidson CJ; Hlatky M; Morris KG; Pieper K; Skelton TN; Schwab SJ; Bashore TM
Ann Intern Med; 1989 Jan; 110(2):119-24. PubMed ID: 2909204
[TBL] [Abstract][Full Text] [Related]
13. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents.
Deray G; Bellin MF; Boulechfar H; Baumelou B; Koskas F; Baumelou A; Grellet J; Jacobs C
Am J Nephrol; 1991; 11(4):309-12. PubMed ID: 1799190
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
[TBL] [Abstract][Full Text] [Related]
16. The effects of ioxaglate 320, iohexol 350, and iopamidol 370 on erythrocyte aggregation.
Hayes R; Mahon T; Masterson J; Owens A
Invest Radiol; 1991 Aug; 26(8):742-4. PubMed ID: 1917410
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study.
Gertz EW; Wisneski JA; Miller R; Knudtson M; Robb J; Dragatakis L; Browne KF; Vetrovec G; Smith SC
J Am Coll Cardiol; 1992 Apr; 19(5):899-906. PubMed ID: 1552109
[TBL] [Abstract][Full Text] [Related]
18. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
19. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
Rudnick MR; Goldfarb S; Wexler L; Ludbrook PA; Murphy MJ; Halpern EF; Hill JA; Winniford M; Cohen MB; VanFossen DB
Kidney Int; 1995 Jan; 47(1):254-61. PubMed ID: 7731155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
